The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Bio-Techne Corp’s current trading price is -30.50% away from its 52-week high, while its distance from the 52-week low is 26.32%. The stock’s price range for this period has been between $46.01 and $83.62 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.46 million for the day, a number notably lower than the average daily volume of 2.26 million over the last three months.
The present stock price for Bio-Techne Corp (TECH) is $58.12. In the last trading session, the stock made a considerable jump, reaching $80.0 after an opening price of $58.03. The stock briefly fell to $51.0 before ending the session at $55.31.
Bio-Techne Corp saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $83.62 on 07/31/24, while the lowest price for the same duration was marked at $46.01 on 04/21/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Bio-Techne Corp (TECH) has experienced a quarterly rise of 15.87% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.11B and boasts a workforce of 3100 employees.
Bio-Techne Corp: What Analysts Are Saying
As of right now, 10 analysts are rating Bio-Techne Corp as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 5 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 52.97, with a change in price of -3.86. Similarly, Bio-Techne Corp recorded 2,219,608 in trading volume during the last 100 days, posting a change of -6.25%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for TECH stands at 0.21. Similarly, the long-term debt-to-equity ratio is also 0.20.
TECH Stock Stochastic Average
As of today, Bio-Techne Corp’s raw stochastic average for the last 50 days stands at 94.95%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 92.85%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 81.43% and 62.25%, respectively.
TECH Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -25.27% this year. Over the last six months, there has been a stronger performance of -26.16%. The price of TECH fallen by 16.24% during the last 30 days period. For the last 5-days stocks have improved 9.06%.
